Litcius/Paper detail

A Stimulated FT–IR Biospectroscopic Study of Ritonavir Protective and Therapeutic Effect as a Potent Drug on Coronavirus Disease–2019 (COVID–19) Infection

Alireza Heidari

2020Saudi Journal of Biomedical Research24 citationsDOIOpen Access PDF

Abstract

Ritonavir is an antiretroviral of the protease inhibitor class. It is used against HIV infections as a fixed-dose combination with another protease inhibitor, ritonavir (lopinavir/ritonavir). In the current research, the stimulated FT-IR biospectroscopy of liquid sample of Ritonavir was investigated. The stimulated FT-IR diffractions emitted through focusing the second harmonic laser beam Nd:YAG into the sample were recorded by Echelle spectrometer and ICCD detector. Increasing the energy of laser beam from 2.6 (mJ) to 16 (mJ) was led to increase in stimulated FT-IR signal but after breakdown threshold of liquid sample, more increasing of energy was led to decrease in stimulate FT-IR signals and for energies higher than 20 (mJ), they were disappeared.

Topics & Concepts

Coronavirus disease 2019 (COVID-19)RitonavirDrugCoronavirusVirologyMedicine2019-20 coronavirus outbreakDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug repositioningPharmacologyInfectious disease (medical specialty)VirusViral loadInternal medicineOutbreakAntiretroviral therapySpectroscopy Techniques in Biomedical and Chemical Researchthermodynamics and calorimetric analysesLiver Disease Diagnosis and Treatment